Schonfeld Strategic Advisors LLC Nuvasive Inc Transaction History

Schonfeld Strategic Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $896,280 - $1 Million	14,000 New	14,000 $949,000
Q1 2021 May 17, 2021	SELL	$53.26 - $68.08 $2.59 Million - $3.31 Million	-48,650 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$43.41 - $56.51 $2.11 Million - $2.75 Million	48,650 New	48,650 $2.74 Million
Q3 2020 Nov 16, 2020	SELL	$47.43 - $60.75 $1.95 Million - $2.5 Million	-41,138 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.51 - $66.59 $842,788 - $1.29 Million	19,370 Added 88.98%	41,138 $2.29 Million
Q1 2020 May 15, 2020	BUY	$32.82 - $81.13 $714,425 - $1.77 Million	21,768 New	21,768 $1.1 Million
Q1 2019 May 15, 2019	SELL	$44.53 - $58.9 $1.3 Million - $1.72 Million	-29,140 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$47.64 - $71.26 $1.39 Million - $2.08 Million	29,140 New	29,140 $1.44 Million
Q3 2018 Nov 14, 2018	SELL	$52.03 - $71.41 $228,932 - $314,204	-4,400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$48.15 - $56.68 $211,860 - $249,392	4,400 New	4,400 $229,000
Q1 2018 May 15, 2018	SELL	$46.03 - $61.28 $332,612 - $442,809	-7,226 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$50.58 - $60.79 $365,491 - $439,268	7,226	7,226 $423,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.